← Back to Search

Behavioural Intervention

Low Sudden Sound Reduction for Hearing Loss

N/A
Waitlist Available
Led By Joshua Alexander, Ph.D.
Research Sponsored by Purdue University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, on average 2 hours
Awards & highlights

Study Summary

This trial will examine how adjusting hearing aid settings to manage sudden sounds affects speech comprehension and recall in people with hearing loss. Participants will undergo tests to assess their hearing, medical history, and cognitive abilities.

Who is the study for?
This trial is for individuals with hearing loss who can hear sounds between 25-70 dB HL from 2000 - 6000 Hz and are native English speakers. It's not suitable for those with retrocochlear hearing loss, which involves issues beyond the cochlea in the inner ear.Check my eligibility
What is being tested?
The study tests how different sudden sound reduction settings on hearing aids affect speech understanding and memory. Participants will be evaluated through listening experiments to measure sentence recognition and recall, as well as subjective comfort ratings.See study design
What are the potential side effects?
While there aren't direct side effects like in drug trials, participants may experience discomfort or dissatisfaction with certain sudden sound reduction settings based on personal preference and performance during the tests.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, on average 2 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, on average 2 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Preference
Recall
Speech recognition

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Maxiumum Sudden Sound ReductionExperimental Treatment1 Intervention
Each participant will listen to recordings of sentences processed by a hearing aid with settings for treating sudden sounds set to Maximum.
Group II: Low Sudden Sound ReductionExperimental Treatment1 Intervention
Each participant will listen to recordings of sentences processed by a hearing aid with settings for treating sudden sounds set to Low.
Group III: High Sudden Sound ReductionExperimental Treatment1 Intervention
Each participant will listen to recordings of sentences processed by a hearing aid with settings for treating sudden sounds set to High.
Group IV: ControlActive Control1 Intervention
Each participant will listen to recordings of sentences processed by a hearing aid with settings for treating sudden sounds set to OFF.

Find a Location

Who is running the clinical trial?

Purdue UniversityLead Sponsor
226 Previous Clinical Trials
72,824 Total Patients Enrolled
1 Trials studying Hearing Loss
60 Patients Enrolled for Hearing Loss
OticonUNKNOWN
1 Previous Clinical Trials
40 Total Patients Enrolled
1 Trials studying Hearing Loss
40 Patients Enrolled for Hearing Loss
Joshua Alexander, Ph.D.Principal InvestigatorPurdue University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial include individuals who are above the age of 65?

"Individuals as young as 18 and up to the age of 79 are eligible for inclusion in this research."

Answered by AI

Are participants currently being recruited for this study?

"The ongoing trial, initially posted on 2/21/2024 and most recently updated on 3/31/2024, is not actively enrolling participants according to clinicaltrials.gov. However, it's essential to note that there are currently 160 alternative trials seeking candidates for participation."

Answered by AI

Who else is applying?

What site did they apply to?
Purdue University
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

find a cure for hearing loss.
PatientReceived no prior treatments
~34 spots leftby Sep 2024